OBS

OBS, established in 1963, is a prominent entity within the Pharmaceutical and Healthcare industries, operating through a strategic structure of five distinct sister companies: OBS Pakistan (formerly Merck Sharp & Dohme of Pakistan), Schering Plough Pakistan, OBS Healthcare (formerly Organon Pakistan), OBS Pharma, and Aklima Clinical Research. This diversified operational model allows OBS to cultivate deep expertise across critical health segments. The company has developed significant capabilities in areas such as Cardiology, Neuropsychiatry, Anti-Infectives, Gastroenterology, Gynecology, Ophthalmology, Pulmonology, Endocrinology, Vaccines, and Bone Disorders, underscoring its commitment to comprehensive patient care and medical advancement.

With a revenue of $24.0M and an employee range of 500 - 1,000 individuals, OBS demonstrates substantial operational scale. The company's single listed location in Karachi, Pakistan, serves as a hub for its extensive operations. OBS is dedicated to advancing healthcare solutions through its specialized divisions, each contributing unique strengths to the group's overall mission. Meet OBS's team to understand the professionals driving its success in these specialized medical fields.

The company's product portfolio, while broadly categorized, is underpinned by its deep therapeutic area knowledge. OBS Pharma, for instance, focuses on branded generics, ensuring wider accessibility to essential medications. This strategic approach, combined with its long-standing presence since 1963, positions OBS as a key player in the regional pharmaceutical landscape, committed to innovation and quality in healthcare delivery.